Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 9/2022

12.03.2022 | Original Article

Abbreviated scan protocols to capture 18F-FDG kinetics for long axial FOV PET scanners

verfasst von: Varsha Viswanath, Hasan Sari, Austin R. Pantel, Maurizio Conti, Margaret E. Daube-Witherspoon, Clemens Mingels, Ian Alberts, Lars Eriksson, Kuangyu Shi, Axel Rominger, Joel S. Karp

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Kinetic parameters from dynamic 18F-fluorodeoxyglucose (FDG) imaging offer complementary insights to the study of disease compared to static clinical imaging. However, dynamic imaging protocols are cumbersome due to the long acquisition time. Long axial field-of-view (LAFOV) PET scanners (> 70 cm) have two advantages for dynamic imaging over clinical PET scanners with a standard axial field-of-view (SAFOV; 16–30 cm). The large axial coverage enables multi-organ dynamic imaging in a single bed position, and the high sensitivity may enable clinically routine abbreviated dynamic imaging protocols.

Methods

In this work, we studied two abbreviated protocols using data from a 65-min dynamic 18F-FDG scan: (A) dynamic imaging immediately post-injection (p.i.) for variable durations, and (B) dynamic imaging immediately p.i. for variable durations plus a 1-h p.i. (5-min-long) datapoint. Nine cancer patients were imaged on the Biograph Vision Quadra (Siemens Healthineers). Time-activity curves over the lesions (N = 39) were fitted using the Patlak graphical analysis and a 2-tissue-compartment (2C, k4 = 0) model for variable scan durations (5–60 min). Kinetic parameters from the complete dataset served as the reference. Lesions from all cancers were grouped into low, medium, and high flux groups, and bias and precision of Ki (Patlak) and Ki, K1, k2, and k3 (2C) were calculated for each group.

Results

Using only early dynamic data with the 2C (or Patlak) model, accurate quantification of Ki required at least 50 (or 55) min of dynamic data for low flux lesions, at least 30 (or 40) min for medium flux lesions, and at least 15 (or 20) min for high flux lesions to achieve both 10% bias and precision. The addition of the final (5-min) datapoint allowed for accurate quantification of Ki with a bias and precision of 10% using only 10–15 min of early dynamic data for either model.

Conclusion

Dynamic imaging for 10–15 min immediately p.i. followed by a 5-min scan at 1-h p.i can accurately and precisely quantify 18F-FDG on a long axial FOV scanner, potentially allowing for more widespread use of dynamic 18F-FDG imaging.
Literatur
1.
Zurück zum Zitat Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50:122S-S150.CrossRef Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50:122S-S150.CrossRef
2.
Zurück zum Zitat Visser EP, Boerman OC, Oyen WJ. SUV: from silly useless value to smart uptake value. J Nucl Med. 2010;51:173–5.CrossRef Visser EP, Boerman OC, Oyen WJ. SUV: from silly useless value to smart uptake value. J Nucl Med. 2010;51:173–5.CrossRef
3.
Zurück zum Zitat Lodge MA. Repeatability of SUV in oncologic 18F-FDG PET. J Nucl Med. 2017;58:523–32.CrossRef Lodge MA. Repeatability of SUV in oncologic 18F-FDG PET. J Nucl Med. 2017;58:523–32.CrossRef
5.
Zurück zum Zitat Beaulieu S, Kinahan P, Tseng J, Dunnwald LK, Schubert EK, Pham P, et al. SUV varies with time after injection in 18F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med. 2003;44:1044–50.PubMed Beaulieu S, Kinahan P, Tseng J, Dunnwald LK, Schubert EK, Pham P, et al. SUV varies with time after injection in 18F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med. 2003;44:1044–50.PubMed
6.
Zurück zum Zitat Tseng J, Dunnwald LK, Schubert EK, Link JM, Minoshima S, Muzi M, et al. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. J Nucl Med. 2004;45:1829–37.PubMed Tseng J, Dunnwald LK, Schubert EK, Link JM, Minoshima S, Muzi M, et al. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. J Nucl Med. 2004;45:1829–37.PubMed
7.
Zurück zum Zitat Doot RK, Kurland BF, Kinahan PE, Mankoff DA. Design considerations for using PET as a response measure in single site and multicenter clinical trials. Acad Radiol. 2012;19:184–90.CrossRef Doot RK, Kurland BF, Kinahan PE, Mankoff DA. Design considerations for using PET as a response measure in single site and multicenter clinical trials. Acad Radiol. 2012;19:184–90.CrossRef
8.
Zurück zum Zitat Doot RK, McDonald ES, Mankoff DA. Role of PET quantitation in the monitoring of cancer response to treatment: review of approaches and human clinical trials. Clin Transl Imaging. 2014;2:295–303.CrossRef Doot RK, McDonald ES, Mankoff DA. Role of PET quantitation in the monitoring of cancer response to treatment: review of approaches and human clinical trials. Clin Transl Imaging. 2014;2:295–303.CrossRef
9.
Zurück zum Zitat Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, Wu H, Burger C, Bernd L, et al. The role of quantitative 18F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med. 2002;43:510–8.PubMed Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, Wu H, Burger C, Bernd L, et al. The role of quantitative 18F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med. 2002;43:510–8.PubMed
10.
Zurück zum Zitat Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M, Burger C, Heichel T, Willeke F, et al. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading. J Nucl Med. 2001;42:713–20.PubMed Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M, Burger C, Heichel T, Willeke F, et al. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading. J Nucl Med. 2001;42:713–20.PubMed
13.
Zurück zum Zitat Karakatsanis NA, Casey ME, Lodge MA, Rahmim A, Zaidi H. Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation–maximization reconstruction. Phys Med Biol. 2016;61:5456.CrossRef Karakatsanis NA, Casey ME, Lodge MA, Rahmim A, Zaidi H. Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation–maximization reconstruction. Phys Med Biol. 2016;61:5456.CrossRef
14.
Zurück zum Zitat Karakatsanis NA, Garibotto V, Rager O, Zaidi H. Continuous bed motion vs. step-and-shoot acquisition on clinical whole-body dynamic and parametric PET imaging. In: Conference Record of the 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference. Piscataway, NJ: IEEE; 2015. pp. 1–6. Karakatsanis NA, Garibotto V, Rager O, Zaidi H. Continuous bed motion vs. step-and-shoot acquisition on clinical whole-body dynamic and parametric PET imaging. In: Conference Record of the 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference. Piscataway, NJ: IEEE; 2015. pp. 1–6.
15.
Zurück zum Zitat Surti S, Pantel AR, Karp JS. Total body PET: why, how, what for? TRPMS. 2020;4:283–92. Surti S, Pantel AR, Karp JS. Total body PET: why, how, what for? TRPMS. 2020;4:283–92.
18.
Zurück zum Zitat Viswanath V, Daube-Witherspoon ME, Pantel AR, Parma MJ, Werner ME, Karp JS. Performance benefits of extending the AFOV of PET scanners. n: Conference Record of the 2020 IEEE Nuclear Science Symposium and Medical Imaging Conference. Piscataway, NJ: IEEE; 2020. pp. 1–7. Viswanath V, Daube-Witherspoon ME, Pantel AR, Parma MJ, Werner ME, Karp JS. Performance benefits of extending the AFOV of PET scanners. n: Conference Record of the 2020 IEEE Nuclear Science Symposium and Medical Imaging Conference. Piscataway, NJ: IEEE; 2020. pp. 1–7.
20.
Zurück zum Zitat Zhang X, Xie Z, Berg E, Judenhofer MS, Liu W, Xu T, et al. Total-body dynamic reconstruction and parametric imaging on the uEXPLORER. J Nucl Med. 2020;61:285–91.CrossRef Zhang X, Xie Z, Berg E, Judenhofer MS, Liu W, Xu T, et al. Total-body dynamic reconstruction and parametric imaging on the uEXPLORER. J Nucl Med. 2020;61:285–91.CrossRef
21.
Zurück zum Zitat Wang G, Nardo L, Parikh M, Lara P, Spencer B, Qi J, et al. Simultaneous imaging of cancer and heart using total-body multiparametric PET on EXPLORER. J Nucl Med. 2021;62(suppl. 1):1447. Wang G, Nardo L, Parikh M, Lara P, Spencer B, Qi J, et al. Simultaneous imaging of cancer and heart using total-body multiparametric PET on EXPLORER. J Nucl Med. 2021;62(suppl. 1):1447.
22.
Zurück zum Zitat Wang Y, Cherry S, Badawi R, Wang G. Effect of dual-input function and dispersion on lung FDG-PET kinetic quantification using the EXPLORER total-body PET/CT scanner. J Nucl Med. 2020;61(suppl. 1):13. Wang Y, Cherry S, Badawi R, Wang G. Effect of dual-input function and dispersion on lung FDG-PET kinetic quantification using the EXPLORER total-body PET/CT scanner. J Nucl Med. 2020;61(suppl. 1):13.
23.
Zurück zum Zitat Sari H, Hong J, Eriksson L, Shi K, Conti M, Alberts I, et al. Kinetic modelling of dynamic 18F-FDG datasets from long axial field-of-view PET scanner. J Nucl Med. 2021;62(suppl. 1):1405. Sari H, Hong J, Eriksson L, Shi K, Conti M, Alberts I, et al. Kinetic modelling of dynamic 18F-FDG datasets from long axial field-of-view PET scanner. J Nucl Med. 2021;62(suppl. 1):1405.
26.
Zurück zum Zitat Sari H, Mingels C, Alberts I, Hu J, Buesser D, Shah V, et al. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long-axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging. 2022;(0123456789). https://doi.org/10.1007/s00259-021-05623-6. Sari H, Mingels C, Alberts I, Hu J, Buesser D, Shah V, et al. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long-axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging. 2022;(0123456789). https://​doi.​org/​10.​1007/​s00259-021-05623-6.
28.
Zurück zum Zitat Cheng G, Torigian DA, Zhuang H, Alavi A. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol imaging. 2013;40:779–87.CrossRef Cheng G, Torigian DA, Zhuang H, Alavi A. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol imaging. 2013;40:779–87.CrossRef
29.
Zurück zum Zitat Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C. Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging. 2021;48:21–39.CrossRef Dimitrakopoulou-Strauss A, Pan L, Sachpekidis C. Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives. Eur J Nucl Med Mol Imaging. 2021;48:21–39.CrossRef
30.
Zurück zum Zitat Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985;5:584–90.CrossRef Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985;5:584–90.CrossRef
32.
Zurück zum Zitat Minn H, Zasadny KR, Quint LE, Wahl RL. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiol. 1995;196:167–73.CrossRef Minn H, Zasadny KR, Quint LE, Wahl RL. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiol. 1995;196:167–73.CrossRef
33.
Zurück zum Zitat Dimitrakopoulou-Strauss A, Strauss LG, Burger C, Rühl A, Irngartinger G, Stremmel W, et al. Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy. J Nucl Med. 2004;45:1480–7.PubMed Dimitrakopoulou-Strauss A, Strauss LG, Burger C, Rühl A, Irngartinger G, Stremmel W, et al. Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy. J Nucl Med. 2004;45:1480–7.PubMed
34.
Zurück zum Zitat Dimitrakopoulou-Strauss A, Georgoulias V, Eisenhut M, Herth F, Koukouraki S, Mäcke HR, et al. Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using 68Ga-DOTATOC PET and comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2006;33:823–30.CrossRef Dimitrakopoulou-Strauss A, Georgoulias V, Eisenhut M, Herth F, Koukouraki S, Mäcke HR, et al. Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using 68Ga-DOTATOC PET and comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2006;33:823–30.CrossRef
35.
Zurück zum Zitat Graham M, Peterson L, Hayward R. Comparison of simplified quantitative analyses of FDG uptake. Nucl Med Biol. 2000;27:647–55.CrossRef Graham M, Peterson L, Hayward R. Comparison of simplified quantitative analyses of FDG uptake. Nucl Med Biol. 2000;27:647–55.CrossRef
36.
Zurück zum Zitat Alberts I, Hünermund J-N, Prenosil G, Mingels C, Bohn KP, Viscione M, et al. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT. Eur J Nucl Med Mol Imaging. 2021:1–10. Alberts I, Hünermund J-N, Prenosil G, Mingels C, Bohn KP, Viscione M, et al. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT. Eur J Nucl Med Mol Imaging. 2021:1–10.
37.
Zurück zum Zitat McCready VR, Dizdarevic S, Beyer T. Lesion detection and administered activity. J Nucl Med. 2020;61:1406–10.CrossRef McCready VR, Dizdarevic S, Beyer T. Lesion detection and administered activity. J Nucl Med. 2020;61:1406–10.CrossRef
38.
Zurück zum Zitat Li Y, Matej S, Karp JS. Practical joint reconstruction of activity and attenuation with autonomous scaling for time-of-flight PET. Phys Med Biol. 2020;65:235037.CrossRef Li Y, Matej S, Karp JS. Practical joint reconstruction of activity and attenuation with autonomous scaling for time-of-flight PET. Phys Med Biol. 2020;65:235037.CrossRef
42.
Zurück zum Zitat Badawi RD, Shi H, Hu P, Chen S, Xu T, Price PM, et al. First human imaging studies with the EXPLORER total-body PET scanner. J Nucl Med. 2019;60:299–303.CrossRef Badawi RD, Shi H, Hu P, Chen S, Xu T, Price PM, et al. First human imaging studies with the EXPLORER total-body PET scanner. J Nucl Med. 2019;60:299–303.CrossRef
Metadaten
Titel
Abbreviated scan protocols to capture 18F-FDG kinetics for long axial FOV PET scanners
verfasst von
Varsha Viswanath
Hasan Sari
Austin R. Pantel
Maurizio Conti
Margaret E. Daube-Witherspoon
Clemens Mingels
Ian Alberts
Lars Eriksson
Kuangyu Shi
Axel Rominger
Joel S. Karp
Publikationsdatum
12.03.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 9/2022
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05747-3

Weitere Artikel der Ausgabe 9/2022

European Journal of Nuclear Medicine and Molecular Imaging 9/2022 Zur Ausgabe